LEADER 04316nam 22012853a 450 001 9910367753003321 005 20250203235434.0 010 $a9783039215492 010 $a3039215493 024 8 $a10.3390/books978-3-03921-549-2 035 $a(CKB)4100000010106187 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/53820 035 $a(ScCtBLL)3f982a17-4060-49b0-a73b-997cc460ff12 035 $a(OCoLC)1163819944 035 $a(oapen)doab53820 035 $a(EXLCZ)994100000010106187 100 $a20250203i20192019 uu 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 04$aThe Molecular and Cellular Basis for Parkinson's Disease$fThomas Müller 210 $cMDPI - Multidisciplinary Digital Publishing Institute$d2019 210 1$aBasel, Switzerland :$cMDPI,$d2019. 215 $a1 electronic resource (230 p.) 311 08$a9783039215485 311 08$a3039215485 330 $aThe focus on dopamine-sensitive motor symptoms, in association with the improvement of motor complications in the heterogeneous disease entity Parkinson's disease, has led to a certain standstill in research.This Special Issue provides new concepts and new ideas on the pathogenesis, genetics, and clinical maintenance of Parkinson's disease and related disorders. Not only new experimental findings, but also clinical outcomes, case series, and research on alternative, non-pharmacological therapies are included.The objective is to bridge the currently increasing gap between experimental and clinical research on Parkinson's disease and related disorders. 606 $aMedicine and Nursing$2bicssc 610 $amicroRNAs 610 $adisease-modifying effects 610 $aSH-SY5Y 610 $ainpatient treatment 610 $asphingolipids 610 $aneurodegeneration 610 $amagnetic resonance spectroscopy 610 $aMO3.13 610 $aschizophrenia 610 $aepigenetics 610 $along-chain acylcarnitine 610 $amolecular mimicry 610 $acurli 610 $amultimodal complex treatment 610 $achlorogenic acid 610 $aglycerophospholipids 610 $acaffeic acid 610 $alipoproteins 610 $amyenteric plexus 610 $aneurometabolites 610 $aHOG 610 $aimmature oligodendrocyte 610 $aautophagy 610 $aoligodendrocyte 610 $ahypochlorite 610 $aalpha-synuclein 610 $amicrobiome 610 $aglucocerebrosidase 610 $aLewy Body Dementia 610 $abrain iron 610 $amesenchymal stem cells 610 $afatty acid ?-oxidation 610 $aGABA 610 $aenteric glial cell 610 $agut-brain axis 610 $amicrobiota 610 $aREM sleep behavior disorders 610 $aredox cycling 610 $amagnetic resonance imaging 610 $adifferentiation 610 $a?-synuclein-mediated pathology 610 $aParkinson disease 610 $aGaucher?s disease 610 $ametallothionein 610 $a[123I]FP-CIT-SPECT 610 $adopaminergic neuron 610 $amature oligodendrocyte 610 $aglycerolipids 610 $aspectroscopy 610 $aneuroinflammation 610 $aexosomes 610 $aimmunotherapy 610 $aDNA methylation 610 $asterol lipids 610 $anigral cells 610 $acell line 610 $acysteinyl-dopamine 610 $amyelin 610 $aparkinsonisms 610 $amultiple sclerosis 610 $arotenone 610 $abrain 610 $afatty acyls 610 $aKrabbe?s disease 610 $aneuroprotection 610 $aDAT 610 $amotor dysfunction 610 $asecretome 610 $amultiprofessional therapy 610 $aParkinson?s disease 610 $aoxidative stress 610 $aalpha-Synuclein 615 7$aMedicine and Nursing 700 $aMüller$b Thomas$0391224 801 0$bScCtBLL 801 1$bScCtBLL 906 $aBOOK 912 $a9910367753003321 996 $aThe Molecular and Cellular Basis for Parkinson's Disease$93020576 997 $aUNINA